Public Policy Resources

Share

Photo of ACS CAN Volunteers at Advocacy Event to Support Cancer Research Funding

Research, Funding and Drug Development

Improvements in outcomes for cancer patients require continued research and innovation.  ACS CAN advocates for robust federal funding for cancer research, as well as research and drug approval policies that accelerate the development of new treatments while still ensuring patient safety.

Research, Funding and Drug Development Resources:

Immunotherapy--How it can Help in the Fight Against Cancer

October 5, 2015

Immunotherapy is a growing area of cancer drug development, and this educational brochure explains in lay language how immunotherapies for cancer work.

ACS CAN Comments on FDA’s Proposed LDT Oversight Framework

February 2, 2015

This letter provides feedback on FDA's proposal to extend oversight to laboratory developed tests (LDTs).  The letter expressed ACS CAN's general support for this change.

Comments on proposed changes to Common Rule protecting research subjects Oct 2011

October 26, 2011

This joint ACS/ ACS CAN letter provided feedback to proposed changes in the "Common Rule," which outlines the ethical requirements for conducting federally funded research with humans. 

  •